When investors and innovators think of the digital approaches to life sciences, it’s often the dramatic “hacking” of biology leveraging technologies such as AI, CRISPR, and now mRNA, that get the limelight. While these innovations are groundbreaking, their impact is supported by an ecosystem of equally important behind-the-scenes players that…